We are live on ! Find out more

3,435 hedge funds and large institutions have $216B invested in Merck in 2023 Q4 according to their latest regulatory filings, with 378 funds opening new positions, 1,245 increasing their positions, 1,486 reducing their positions, and 107 closing their positions.

New
Increased
Maintained
Reduced
Closed

253% more first-time investments, than exits

New positions opened: 378 | Existing positions closed: 107

10% more call options, than puts

Call options by funds: $1.92B | Put options by funds: $1.75B

9% more capital invested

Capital invested by funds: $199B → $216B (+$17.4B)

7% more funds holding

Funds holding: 3,2143,435 (+221)

2.47% more ownership

Funds ownership: 75.65%78.12% (+2.5%)

5% less funds holding in top 10

Funds holding in top 10: 186177 (-9)

16% less repeat investments, than reductions

Existing positions increased: 1,245 | Existing positions reduced: 1,486

Holders
3,435
Holders Change
+221
Holders Change %
+6.88%
% of All Funds
50.07%
Holding in Top 10
177
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-4.84%
% of All Funds
2.58%
New
378
Increased
1,245
Reduced
1,486
Closed
107
Calls
$1.92B
Puts
$1.75B
Net Calls
+$175M
Net Calls Change
-$230M
Name Holding Trade Value Shares
Change
Change in
Stake
OAM
326
Oppenheimer Asset Management
New York
$44.1M -$486K -4,678 -1%
DP
327
Dearborn Partners
Illinois
$43.9M -$887K -8,546 -2%
NYLIM
328
New York Life Investment Management
New York
$43.7M +$230K +2,211 +0.6%
PL
329
Perpetual Ltd
Australia
$43.7M -$15M -144,340 -26%
MGIM
330
M&G Investment Management
United Kingdom
$43.7M -$629K -6,060 -1%
VPC
331
Vestal Point Capital
New York
$43.6M +$41.5M +400,000 New
CAN
332
Cetera Advisor Networks
California
$43.6M -$1.62M -15,589 -4%
SCI
333
S&CO Inc
Massachusetts
$43.6M +$275K +2,645 +0.7%
MHI
334
Miller Howard Investments
New York
$43.3M -$29.4M -283,388 -42%
UH
335
Unigestion Holding
Switzerland
$42.5M -$9.91M -95,444 -20%
BF
336
BOK Financial
Oklahoma
$41.7M -$861K -8,292 -2%
WF
337
Welch & Forbes
Massachusetts
$41.5M -$1.28M -12,375 -3%
Los Angeles Capital Management
338
Los Angeles Capital Management
California
$41M +$9.56M +92,146 +32%
ACIM
339
Azimuth Capital Investment Management
Michigan
$40.9M +$9.75M +93,941 +33%
SPS
340
Susquehanna Portfolio Strategies
Pennsylvania
$40.8M +$38.8M +374,082 New
VDI
341
Vaughan David Investments
Illinois
$40.6M +$366K +3,530 +1%
TRCT
342
Tower Research Capital (TRC)
New York
$40.6M +$26.3M +253,535 +214%
CAM
343
Cresset Asset Management
Illinois
$40.2M -$94K -906 -0.2%
AIM
344
Achmea Investment Management
Netherlands
$40.1M -$4.98M -47,998 -12%
SPIA
345
Steward Partners Investment Advisory
New York
$40.1M +$397K +3,826 +1%
TC
346
TownSquare Capital
Utah
$39.6M -$2.49M -23,992 -6%
AG
347
AIA Group
Hong Kong
$39.3M +$4.75M +45,797 +15%
PWP
348
Private Wealth Partners
California
$37.9M +$128K +1,229 +0.4%
OCBCO
349
Oversea-Chinese Banking Corp (OCBC)
Singapore
$37.8M +$1.9M +18,333 +6%
BCM
350
Becker Capital Management
Oregon
$37M -$834K -8,032 -2%

MRK Hedge Fund Activity: Q4 2023 in Review

3,435 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2023, worth a combined $216B — up 8.8% from $199B a quarter earlier.

Buyers outnumbered sellers: 378 funds opened new MRK positions and 107 closed out — a net gain of 271 holders — while 1,245 added to existing stakes and 1,486 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $4.32B. The largest seller was Bank of New York Mellon, cutting an estimated $432M.

  • 3,435 institutional investors held Merck (MRK) as of Q4 2023, up from 3,214 in Q3 2023.
  • Funds reported $216B of Merck stock for Q4 2023, up 8.8% quarter-over-quarter.
  • 378 funds opened new Merck positions in Q4 2023 and 107 closed out, a net change of +271 holders.
  • The largest Merck buyer in Q4 2023 was Morgan Stanley, an estimated $4.32B added.
  • The largest Merck seller in Q4 2023 was Bank of New York Mellon, an estimated $432M sold.

Based on aggregated 13F filings for Q4 2023.